ELAC2 p.Arg104Cys
c.310C>T · rs748205884 · VCV1356617
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1901 | likely benign |
|---|---|---|
| REVEL | 0.253 | benign-leaning |
| SaProt | LLR -11.51 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense and REVEL do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 1.6, phastCons 1 |
| Regional constraint | o/e 1.03 | unconstrained · MANE · 25 kb · p 0.4 · regional, not allelic |
| Overall | ||
| CADD | 34.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.00134% | 74,864 |
| South Asian | 0.0011% | 91,076 |
| European (non-Finnish) | 0.000763% | 131,113 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ELAC2
- Protein
- p.Arg104Cys
- Coding
- c.310C>T
- MANE Select
- NM_018127
- dbSNP
- rs748205884
- Type
- single nucleotide variant
- Location
- chr17:13016919 (GRCh38)
- Gene constraint
- LOEUF 1.02 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 82.81 · 10 PDB
- Residue 104
- an α-helix
Similar variants
- ELAC2 p.Arg104His Uncertain significance ★ ⚠ same residue
- ELAC2 c.1080-1G>C Likely pathogenic ★★ same condition
- ELAC2 c.1423+1G>A Pathogenic ★★ same condition
- ELAC2 c.1908+1G>A Likely pathogenic ★★ same condition
- ELAC2 c.245+2T>A Pathogenic/Likely pathogenic ★★ same condition
- ELAC2 p.Arg497Ter Pathogenic/Likely pathogenic ★★ same condition
- ELAC2 p.Gln18Ter Pathogenic ★★ same condition
- ELAC2 p.Glu30Ter Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/elac2-p-arg104cys (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown